Literature DB >> 3498817

Comparison of in vitro actions with behavioral effects of antimuscarinic agents.

J M Witkin1, R K Gordon, P K Chiang.   

Abstract

In vitro potencies of a series of muscarinic antagonists were compared with their effects on operant behavior. Ki values for inhibition of [3H]N-methylscopolamine binding in N4TG1 neuroblastoma cells correlated positively with ED50 values for the inhibition of carbachol-induced alpha-amylase release from pancreatic acini cells and with KB values for inhibition of acetylcholine-induced contractions of guinea pig ileum. The rank order of potency for inhibition of [3H]N-methylscopolamine binding was quinuclidinyl benzilate = quinuclidinyl xanthene-9-carboxylate greater than (methyl atropine = atropine) greater than benactyzine greater than azaprophen greater than (adiphenine = aprophen) greater than pirenzepine greater than ethyl aprophen. The M1 antagonist, pirenzepine, was a weak inhibitor in the guinea pig ileum and alpha-amylase assays relative to its ability to inhibit [3H]N-methylscopolamine binding; azaprophen exhibited the opposite relationship. Lever-press responses of rats were maintained by food delivery under a schedule requiring 10 responses for each food presentation. The high response rates engendered by this schedule were decreased in a dose-dependent manner by all compounds. The order of potency for this behavioral effect (ED50) was atropine = azaprophen greater than aprophen greater than (methyl atropine = benactyzine) greater than pirenzepine greater than adiphenine. Behavioral depressant actions of the antimuscarinics correlated positively with their potencies in inhibiting alpha-amylase secretion. Pirenzepine was unique in being relatively more potent in its behavioral effects than in its actions in vitro. In contrast to the other antimuscarinic agents studied, the benzilates, benactyzine, aprophen and adiphenine, but not azaprophen, increased behavioral response rates.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498817

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Central versus peripheral effects of muscarinic antagonists: the limitations of quaternary ammonium derivatives.

Authors:  H Moore; P Dudchenko; K S Comer; J P Bruno; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Assessment of working memory in rats using spatial alternation behavior with variable retention intervals: effects of fixed-ratio size and scopolamine.

Authors:  H E Shannon; K G Bemis; J C Hart
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats.

Authors:  P Worms; C Gueudet; A Pério; P Soubrié
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.

Authors:  J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Comparison of the muscarinic antagonist effects of scopolamine and L-687,306.

Authors:  Gail Winger; Emily M Jutkiewicz; James H Woods
Journal:  Behav Pharmacol       Date:  2020-06       Impact factor: 2.277

6.  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition.

Authors:  Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Gail Winger; Jack Bergman; Andrew Coop; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2021-03-12       Impact factor: 4.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.